ReviewProstate cancer and prostatic diseases2026
Modern active surveillance in low- and intermediate-risk prostate cancer without re-biopsy.
Jale Lakes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it